Category Archives: Top Market News

miRagen Therapeutics Inc Receives a Buy from Wedbush

In a report released today, Liana Moussatos from Wedbush reiterated a Buy rating on miRagen Therapeutics Inc (NASDAQ: MGEN). The company’s shares opened today at $9.10. According to TipRanks.com, Moussatos is a 4-star analyst with an average return of 7.5%

BMO Capital Keeps Their Hold Rating on Infosys Limited

In a report released today, Keith Bachman from BMO Capital reiterated a Hold rating on Infosys Limited (NYSE: INFY), with a price target of $16. The company’s shares opened today at $15.09. According to TipRanks.com, Bachman is a 5-star analyst

Epam Systems Inc Received its Third Buy in a Row

After Cowen & Co. and Cantor Fitzgerald assigned a Buy rating to Epam Systems Inc in the last month, the company received another Buy, this time from Jefferies. Analyst Steven Desanctis reiterated a Buy rating on Epam Systems Inc (NYSE:

Jefferies Sticks to Its Hold Rating for Leidos Holdings

In a report released yesterday, Sheila Kahyaoglu from Jefferies reiterated a Hold rating on Leidos Holdings (NYSE: LDOS), with a price target of $52. The company’s shares opened today at $55.83, close to its 52-week high of $57.76. According to

Nektar Therapeutics Receives a Buy from Jefferies

In a report issued on August 16, David Steinberg from Jefferies reiterated a Buy rating on Nektar Therapeutics (NASDAQ: NKTR), with a price target of $23. The company’s shares opened today at $18.28. According to TipRanks.com, Steinberg is a 4-star

Analysts Offer Insights on Healthcare Companies: Pfizer (NYSE: PFE), Immunomedics (NASDAQ: IMMU) and Tesaro (NASDAQ: TSRO)

Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on Pfizer (NYSE: PFE), Immunomedics (NASDAQ: IMMU) and Tesaro (NASDAQ: TSRO). Pfizer (NYSE: PFE) Jefferies analyst David Steinberg reiterated a Hold rating on Pfizer